Sreekumar Balan

7PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyNanomedicinePredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 10, 2026
Leveraging cDC1 biology and function for enhanced immunotherapy.

|Feb 26, 2026
A Tumor-Promoting Inflammatory SPP1+ Macrophage-IL6-CRP Axis Drives Immune Dysfunction in Bladder Cancer.

Michelle A Tran, Byuri Angela Cho, Sudeh Izadmehr

|Jul 02, 2025
Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications.

Sreekumar Balan, Liam O'Brien, Ante Peros

|Jan 21, 2025
Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer.

Meriem Belabed, Matthew D Park, Cédric M Blouin

|Feb 05, 2022
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets.

Nina Bhardwaj, Philip A Friedlander, Anna C Pavlick

|Nov 09, 2019
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma.

Anna Pavlick, Ana B Blazquez, Marcia Meseck

Pageof 2

Frequent Collaborators

5 joint publications

Nina Bhardwaj

2 joint publications

Christopher Mcclain

2 joint publications

Sacha Gnjatic

2 joint publications

Kristen J Radford